An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 253 participants.
Also called NCT01725646
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 253 participants
- Sponsor
- Excelsior
- Registry
-
NCT01725646
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT01725646. Randomized; quadruple masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2013-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients
- Condition
- Hypertriglyceridemia
- Intervention (Drug)
- Omacor®
- Intervention (Drug)
- Placebo
- Lead sponsor
- Excelsior
Record details
- Record id
cardio:ct-nct01725646- Content hash
3b3ca6e468d4e94cbd1744973f969fae52e8e2a136b762a5a90aeefddd48a23d